Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Pharmacology|September 30, 1998
Pharmacokinetics of oral and intravenous dolasetron mesylate in patients with renal impairmentD C Dimmitt, A K Shah, T Arumugham, et al.The Annals of Pharmacotherapy|February 26, 1998
Effect of infusion rate on the pharmacokinetics and tolerance of intravenous dolasetron mesylateD C Dimmitt, T L Hunt, A J Spalitto, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 1998
Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trialsJ B Whitmore, M G Kris, P J Hesketh, et al.American Journal of Clinical Oncology|December 1, 1996
Antiemetic efficacy of two different single intravenous doses of dolasetron in patients receiving high-dose cisplatin-containing chemotherapyA Yeilding, L Bertoli, P Eisenberg, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 1996
Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamideP J Hesketh, D R Gandara, A M Hesketh, et al.Pageof 2